Table 3 Major cancer vaccine technologies.
From: Data mining of cancer vaccine trials: a bird's-eye view
Vaccine antigen status | Vaccine technology |
|---|---|
Defined antigen | Dendritic cell (peptide) |
| Â | Dendritic cell (protein) |
| Â | Dendritic cell (specific RNA) |
| Â | Dendritic cell (virus) |
| Â | Viral vector (antigen) |
| Â | Viral vector (other) |
| Â | Naked DNA |
| Â | Protein |
| Â | Peptides |
| Â | Anti-idiotype |
| Â | Antigen-specific adjuvant |
| Â | Other |
Undefined antigen | Dendritic cells (tumor cell pulsed) |
| Â | Dendritic cells (lysate pulsed) |
| Â | Dendritic cells (allo-lysate pulsed) |
| Â | Allogeneic Dendritic cells (lysate pulsed) |
| Â | Dendritic cells (antigen) |
| Â | Dendritic cells (non-specific DNA) |
| Â | Dendritic cells (non-specific RNA) |
| Â | Dendritic cells (idiotype) |
| Â | Oncolytic virus |
| Â | Autologous (tumor lysate) |
| Â | Allogeneic (tumor lysate) |
| Â | Autologous (tumor cell) |
| Â | Allogeneic (tumor cell) |
| Â | Autologous (T cell) |
| Â | Autologous (lymphocytes) |
| Â | Autologous (PBMC) |
| Â | Immunomodulators |
| Â | Immune activators |
| Â | Other non-cancer vaccines |
| Â | Other |